Search BRITE hierarchies
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AC Selective beta-2-adrenoreceptor agonists
R03AC19 Olodaterol [DG:DG01058]
D10020 Olodaterol hydrochloride (JAN/USAN) <US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilators, Sympathomimetic
Olodaterol [DG:DG01058]
D10020 Olodaterol hydrochloride (JAN/USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01058 Olodaterol
D10020 Olodaterol hydrochloride
Metabolizing enzyme substrate
DG02918 CYP2C8 substrate
DG01058 Olodaterol
D10020 Olodaterol hydrochloride
DG01642 CYP2C9 substrate
DG01058 Olodaterol
D10020 Olodaterol hydrochloride
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG01058 Olodaterol
D10020 Olodaterol hydrochloride
DG03185 UGT1A7 substrate
DG01058 Olodaterol
D10020 Olodaterol hydrochloride
DG03188 UGT1A9 substrate
DG01058 Olodaterol
D10020 Olodaterol hydrochloride
DG03190 UGT2B7 substrate
DG01058 Olodaterol
D10020 Olodaterol hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2 [HSA:154] [KO:K04142]
D10020 Olodaterol hydrochloride (JAN/USAN) <US>
New drug approvals in the USA [br08319.html]
D10020
New drug approvals in the USA, Europe and Japan [br08328.html]
D10020
Drug metabolizing enzymes and transporters [br08309.html]
D10020
[ BRITE | KEGG2 | KEGG ]